Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Ticker
Market factors today
Unlock the full LIMN picture
About Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
LIMN stock facts
| Ticker symbol | LIMN |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $5.7M |
| CEO | Chris Kim |
| Employees | 1 |
| Headquarters | Cerritos, CA, US |
| IPO date | 2025-05-01 |
| Website | liminatuspharma.com |
What you can see for LIMN on Tickr
Live LIMN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LIMN report.
Rankings
FAQ
What is the ticker symbol for Liminatus Pharma, Inc. Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. Class A Common Stock is LIMN, listed on the NASDAQ Global Select.
What is LIMN?
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.